Valuation: Boston Scientific Corporation

Market Cap 70.19B 60.94B 56.82B 52.2B 98.72B 6,676B 99.8B 670B 262B 3,337B 264B 258B 11,058B P/E 2026 *
18x
P/E 2027 * 18.8x
Enterprise Value 79.56B 69.08B 64.41B 59.17B 112B 7,568B 113B 759B 297B 3,783B 299B 292B 12,535B EV / Sales 2026 *
3.72x
EV / Sales 2027 * 3.42x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day+0.90%
1 week+6.58%
Current month+5.05%
1 month+10.07%
3 months-13.65%
6 months-34.98%
Current year-48.52%
1 week 42.55
Extreme 42.55
49.21
1 month 42.2
Extreme 42.2
49.21
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Fiscal year

Chief Financial Officer

5,184 0.0004%
01/03/26 Fiscal year

Controller/Auditor

2,048 0.0001%
19/02/26 Other

Executive/Senior Manager

6,851 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
+1.36%+6.58%-54.03%-3.21% 70.19B
-1.62%-2.02%+21.04%+2.94% 212B
-1.38%-2.15%-1.36%-23.54% 139B
-1.90%+1.79%-23.81%+19.06% 133B
+0.88%+7.07%+11.87%+12.63% 51.14B
-0.28%+9.67%-16.00%-19.59% 50.09B
-0.43%-0.95%+21.21%+10.21% 39.48B
+5.69%+3.17%+38.69%+36.63% 36.79B
+2.45%+5.20%+106.23%+8.17% 29.92B
+0.76%+9.59%-0.54%-7.43% 31.5B
Average +0.64%+4.99%+10.33%+3.59% 79.28B
Weighted average by Cap. -0.36%+3.97%+3.22%+1.37%

Financials

2026 *2027 *
Net sales 21.37B 18.55B 17.3B 15.89B 30.05B 2,032B 30.38B 204B 79.72B 1,016B 80.24B 78.48B 3,366B 22.34B 19.4B 18.08B 16.61B 31.42B 2,125B 31.76B 213B 83.34B 1,062B 83.88B 82.04B 3,519B
Net income 3.86B 3.35B 3.12B 2.87B 5.42B 367B 5.48B 36.81B 14.39B 183B 14.48B 14.16B 608B 3.74B 3.25B 3.03B 2.78B 5.26B 356B 5.32B 35.68B 13.95B 178B 14.04B 13.73B 589B
Net Debt 9.37B 8.14B 7.59B 6.97B 13.18B 892B 13.33B 89.46B 34.97B 446B 35.2B 34.43B 1,477B 6.29B 5.46B 5.09B 4.68B 8.84B 598B 8.94B 60.02B 23.46B 299B 23.61B 23.1B 991B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
05/08/26 $49.09 +1.36% 21,210,621
03/08/26 $48.43 +3.64% 20,379,998
31/07/26 $46.73 +1.59% 18,691,884
30/07/26 $46.00 -0.09% 25,894,477
29/07/26 $46.04 -0.04% 51,286,660
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
48.43USD
Average target price
62.69USD
Spread / Average Target
+29.44%

Quarterly revenue - Rate of surprise